Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (543)	5/13/1999 6:10:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 4474

Ariad management certainly has some choices to make. I wish they would make those descisions soon. For me, having cash parked in dead stocks such as this is very frustrating--especially with a few of the big names in biotech really perking up of late, what was up with Incyte today--talk about a tradable stock lately. I'd hoped that out of aria, ntii, cnsi, ctii--all that third tier cheap stuff I'm locked up in-- that something would have paid off by now. I'm really getting ichy feet to go jump on something that is actually moving. Good example of how a person can freeze up and do nothing: That ctii is one of five stocks I have on my stem cell watch list. Meanwhile, Vimrx, another on that list, has been just romping on upward. But I just cant seem to get myself to jump on for the ride. Funny, a year ago, I'd have no problem liquidating my entire portfolio just to hop on a hot stock, nowdays I'm completely frozen, strange. I hope I have not brainwashed myself into thinking I'm actually investing in something--that's a sure way to be punished for good intentions.